Company / Depreciation & Amortization
CRESCENT BIOPHARMA, INC. Depreciation & Amortization History
FY2014-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$191.5K
FY2017
5-year range
$99.9K / $191.5K
FY2014-FY2017
Trend
+20.7%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $99,923 in FY2014 to $191,484 in FY2017.
Based on SEC 10-K filings.
$191,484 in FY2017 with a 3-year CAGR of +24.2%.
Increased from $133,051 to $191,484 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +24.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- CRESCENT BIOPHARMA, INC.'s depreciation & amortization has grown for 3 consecutive years.
- 3-year CAGR of +24.2%, indicating consistent growth.
- In FY2017, depreciation & amortization increased 20.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2017 | $191.5K | +20.7% |
| FY2016 | $158.7K | +19.3% |
| FY2015 | $133.1K | +33.2% |
| FY2014 | $99.9K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026